Advertisement
This Article is From Sep 06, 2020

50,000 People Globally Part Of Phase 3 Trial Of Chinese COVID-19 Vaccine

Media reported in July that phase 3 trial of this vaccine will be held in Uzbekistan, and Pakistan has expressed interest in conducting clinical trials as well.

50,000 People Globally Part Of Phase 3 Trial Of Chinese COVID-19 Vaccine
Phase 3 clinical trials of vaccine is accelerating, China National Biotec Group said (Representational)
Beijing:

Around 50,000 people, across a number of countries, are participating in phase 3 clinical trials of a COVID vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in a press release.

"The third phase of clinical trials of the inactivated CNBG vaccine against COVID-19 is significantly accelerating, and clinical trials are already underway in several countries, including Bahrain, UAE, Morocco, Peru, Argentina, with about 50,000 people participating," the CNGB said.

Media reported in July that phase 3 trial of CNBG's vaccine will also be held in Uzbekistan, and Pakistan has expressed interest in conducting clinical trials as well.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Track Latest News Live on NDTV.com and get news updates from India and around the world

Follow us:
Switch To Dark/Light Mode
Previous Article
Trump Campaign Hacked: How Iran, China, Russia Are Targeting US Elections
50,000 People Globally Part Of Phase 3 Trial Of Chinese COVID-19 Vaccine
Vietnam Man, 37, Steals Uncle's Bones From Grave To Extort From Family To Pay Off Debts
Next Article
Vietnam Man, 37, Steals Uncle's Bones From Grave To Extort From Family To Pay Off Debts
Listen to the latest songs, only on JioSaavn.com